Biotechnology Shares in China Biologic Products closed up 21.15% at $99.39 following the announcement on Monday that it has received an unsolicited, preliminary non-binding proposal letter from CCRE Holdings Limited, a wholly-owned subsidiary of CITIC Capital Holdings Limited (together with its affiliates, CITIC), pursuant to which CITIC proposes to acquire all of the outstanding shares of the company not already owned by CITIC for $110 in cash per share. 19 June 2018